| Literature DB >> 23953644 |
M Mirabelli-Badenier1, R Biancheri2, G Morana3, S Fornarino2, L Siri4, M E Celle2, E Veneselli2, A Vincent5, R Gaggero4, M M Mancardi2.
Abstract
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a well-defined autoimmune disorder. Hashimoto's encephalopathy (HE) is a still controversial entity, lacking definite diagnostic criteria. We described a 14-year-old-girl presenting with a clinical picture consistent with the diagnosis of anti-NMDAR encephalitis, confirmed by NMDAR antibody testing. Four years earlier, she had presented a similar episode of acute encephalopathy diagnosed as HE. Anti-NMDAR encephalitis and HE share similar clinical features so that the differential diagnosis can be difficult if specific antibodies are not tested. The correct diagnosis of anti-NMDAR encephalitis is crucial to plan the appropriate management and follow-up, namely in term of oncological screening, since it can be paraneoplastic in origin. We suggest to re-evaluate the clinical history of all subjects with previous HE diagnosis in order to evaluate the possible diagnosis of anti-NMDAR encephalitis and plan the appropriate management of these patients.Entities:
Keywords: Anti-N-methyl-D-aspartate receptor encephalitis; Epilepsy; Hashimoto encephalopathy; Neuronal surface antibodies; Paraneoplastic
Mesh:
Substances:
Year: 2013 PMID: 23953644 DOI: 10.1016/j.ejpn.2013.07.002
Source DB: PubMed Journal: Eur J Paediatr Neurol ISSN: 1090-3798 Impact factor: 3.140